In this article, the author reviews the current understanding of the genetic basis for Down syndrome phenotypes, including congenital heart defects, Alzheimer disease and leukaemia. The potential for Down syndrome therapies is discussed in light of recent progress in the field.
http://ift.tt/2hMRthP
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τετάρτη 28 Δεκεμβρίου 2016
Down syndrome and the complexity of genome dosage imbalance
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου